Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to $5.3 million.

  • Sensus Healthcare's Operating Expenses rose 4104.14% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year increase of 7032.16%. This contributed to the annual value of $16.3 million for FY2024, which is 1314.91% up from last year.
  • Latest data reveals that Sensus Healthcare reported Operating Expenses of $5.3 million as of Q3 2025, which was up 4104.14% from $4.8 million recorded in Q2 2025.
  • Sensus Healthcare's Operating Expenses' 5-year high stood at $7.0 million during Q1 2025, with a 5-year trough of $2.3 million in Q4 2023.
  • Moreover, its 5-year median value for Operating Expenses was $3.7 million (2024), whereas its average is $4.0 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 4605.07% in 2023, then skyrocketed by 13868.68% in 2024.
  • Quarter analysis of 5 years shows Sensus Healthcare's Operating Expenses stood at $3.5 million in 2021, then rose by 18.12% to $4.2 million in 2022, then tumbled by 46.05% to $2.3 million in 2023, then surged by 138.69% to $5.4 million in 2024, then dropped by 1.82% to $5.3 million in 2025.
  • Its Operating Expenses was $5.3 million in Q3 2025, compared to $4.8 million in Q2 2025 and $7.0 million in Q1 2025.